Titan Biotech Shares Rise After Stock Split
Shares of biological product manufacturer Titan Biotech experienced a 20 % surge, reaching 312 on February 20, following a 1: 5 supply split. The split, introduced in November, aimed to boost liquidity and draw in retail financiers.
- Supply Split: The 1: 5 split raised superior shares fivefold, readjusting the rate to 260 per share.
- Financial Performance: Q 3 FY 26 saw a web revenue of 8 53 crore, up from 4 39 crore year-over-year, with revenue rising 47 6 % to 56 51 crore.
- Shareholding: Marketers hold 55 8 % of the stake, while retail capitalists hold 44 2 %.
